Daniil Gataulin
Stock Analyst at Chardan Capital
(2.69)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FBRX Forte Biosciences | Maintains: Buy | 61 61 | 10.54 | 478.75% | 6 | Aug 15, 2025 | |
ZURA Zura Bio | Maintains: Buy | 10 10 | 1.41 | 609.22% | 1 | Aug 15, 2025 | |
OTLK Outlook Therapeutics | Maintains: Neutral | 3 3 | 1.96 | 53.06% | 9 | Aug 15, 2025 | |
MGTX MeiraGTx Hldgs | Maintains: Buy | 35 35 | 7.83 | 347% | 5 | Aug 15, 2025 | |
TRML Tourmaline Bio | Maintains: Buy | 70 70 | 21.06 | 232.38% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 33 | 2.23 | 1379.82% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 15 | 9.53 | 57.4% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 7.46 | 597.05% | 12 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 0.85 | 370.59% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 27 | 10.28 | 162.65% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 7 | 0.98 | 614.29% | 13 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 38 35 | 14.13 | 147.7% | 5 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 17.99 | 83.44% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | n/a | n/a | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | n/a | n/a | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | 11.17 | 16.38% | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |